If all of that is the case. Then wouldn’t that mean no share price appreciation upon FDA approval?
If all of that is the case. Then wouldn’t that mean no share...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.005(1.41%) |
Mkt cap ! $636.1M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.0¢ | 34.0¢ | $2.246M | 6.430M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 54114 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 80800 | 5 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |